We serve Chemical Name:2-amino-5-cyanobenzamide CAS:606490-51-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-amino-5-cyanobenzamide
CAS.NO:606490-51-1
Synonyms:2-Amino-5-cyanobenzamide;benzamide,2-amino-5-cyano;Benzamide, 2-amino-5-cyano-
Molecular Formula:C8H7N3O
Molecular Weight:161.161
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:344.9±32.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.637
PSA:93.89000
Exact Mass:161.058914
LogP:0.93
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Amino-5-cyanobenzamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzamide, 2-amino-5-cyano- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Amino-5-cyanobenzamide Use and application,Benzamide, 2-amino-5-cyano- technical grade,usp/ep/jp grade.
Related News: Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology. 2-amino-5-cyanobenzamide manufacturer Developing countries such as China and India have good foundations for undertaking global industrial transfers because of their comparative advantages. With the continuous improvement of China’s fine chemical technology level, the types of products and market shares in China’s undertaking industrial transfer have gradually increased. 2-amino-5-cyanobenzamide supplier In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells. 2-amino-5-cyanobenzamide vendor CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion. 2-amino-5-cyanobenzamide factory In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells.
